<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4</volume><submitter>Saha KB</submitter><journal>The Cochrane database of systematic reviews</journal><pagination>CD010631</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7081571</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.</pubmed_title><pmcid>PMC7081571</pmcid><pubmed_authors>Saha KB</pubmed_authors><pubmed_authors>Xia J</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Sampson S</pubmed_authors><pubmed_authors>Bo L</pubmed_authors><pubmed_authors>Zaman RU</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-04T09:05:39.898Z</modification><creation>2025-04-04T09:05:39.898Z</creation></dates><accession>S-EPMC7081571</accession><cross_references><pubmed>27045703</pubmed><doi>10.1002/14651858.CD010631.pub2</doi><doi>10.1002/14651858.cd010631.pub2</doi></cross_references></HashMap>